arrow
Back
V

Vlado Perkovic

University of New South Wales

116H-index
781Paper Count
6.3WCitation Count
Published Papers 291
Publication Date
A meta-analysis of albuminuria as a surrogate endpoint for kidney failure
err2025-11-06
err0
PREAI
errHiddo J. L. Heerspink; Willem H. Collier; Juhi Chaudhari; Shiyuan Miao; Hocine Tighiouart; Gerald B. Appel; Fernando Caravaca-Fontán; Jürgen Floege; Thierry Hannedouche; Enyu Imai; Tazeen H. Jafar; Julia B. Lewis; Philip K. T. Li; Francesco Locatelli; Bart D. Maes; Brendon L. Neuen; Vlado Perkovic; Ronald D. Perrone; Giuseppe Remuzzi; Francesco P. Schena; Christoph Wanner; Tom Greene; Lesley A. Inker
errShare
errSave
Response to the letter to the editor entitled “Semaglutide and kidney function: direct kidney protection or an artifact?”
err2025-10-17
err0
PREAI
errVlado Perkovic; Katherine R. Tuttle; Peter Rossing; Johannes F.E. Mann; Thomas Idorn
errShare
errSave
The Efficacy and Safety of Canagliflozin by Frailty Status in Participants of the CANVAS and CREDENCE Trials
err2025-03-01
err0
errOAAI
errNguyen, Tu N.; Yu, Jie; Perkovic, Vlado; Jardine, Meg; Mahaffey, Kenneth W.; Chow, Clara K.; Arnott, Clare; Lindley, Richard I.
errShare
errSave
Effects of SGLT2 inhibition on insulin use in CKD and type 2 diabetes: insights from the CREDENCE trial
err2025-02-28
err0
PREAI
errBryony Beal; Luke Buizen; Emily K Yeung; Lauren Heath; Lauren Houston; David Z I Cherney; Meg Jardine; Carol Pollock; Clare Arnott; Sradha S Kotwal; Hiddo J L Heerspink; Vlado Perkovic; Brendon L Neuen
errShare
errSave
Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis
err2024-11-26
err1
errOAAI
errNeuen, Brendon L.; Fletcher, Robert A.; Heath, Lauren; Perkovic, Adam; Vaduganathan, Muthiah; Badve, Sunil V.; Tuttle, Katherine R.; Pratley, Richard; Gerstein, Hertzel C.; Perkovic, Vlado; Heerspink, Hiddo J. L.
errShare
errSave
Correlation of Urinary Soluble CD163 LevelsWith Disease Activity and TreatmentResponse in IgA Nephropathy
err2024-10-01
err2
errOAAI
errLi, Jingyi; Lv, Jicheng; Wong, Muh Goet; Shi, Sufang; Zan, Jincan; Monaghan, Helen; Perkovic, Vlado; Zhang, Hong
errShare
errSave
Kidney Disease as a Cardiovascular Disease Priority
err2024-09-24
err0
PREAI
errKotwal, Sradha S.; Perkovic, Vlado
errShare
errSave
Timing of Cardio-Kidney Protection With SGLT2 Inhibitors: Insights From 4 Large-Scale Placebo-Controlled Outcome Trials
err2024-07-23
err1
PREAI
errNeuen, Brendon L.; Claggett, Brian L.; Perkovic, Vlado; Jardine, Meg; Heerspink, Hiddo J. L.; Mahaffey, Kenneth W.; McMurray, John J. V.; Solomon, Scott D.; Vaduganathan, Muthiah
errShare
errSave
The Efficacy and Safety of Reduced-Dose Oral Methylprednisolone in High-Risk Immunoglobulin A Nephropathy
err2024-07-01
err2
errOAAI
errKim, Dana; Lv, Jicheng; Hladunewich, Michelle; Jha, Vivekanand; Hooi, Lai Seong; Monaghan, Helen; Shan, Sana; Reich, Heather N.; Barbour, Sean; Billot, Laurent; Zhang, Hong; Perkovic, Vlado; Wong, Muh Geot
errShare
errSave
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
err2024-06-24
err24
errOAAI
errMann, Johannes F. E.; Rossing, Peter; Bakris, George; Belmar, Nicolas; Bosch-Traberg, Heidrun; Busch, Robert; Charytan, David M.; Hadjadj, Samy; Gillard, Pieter; Gorriz, Jose Luis; Idorn, Thomas; Ji, Linong; Mahaffey, Kenneth W.; Perkovic, Vlado; Rasmussen, Soren; Schmieder, Roland E.; Pratley, Richard E.; Tuttle, Katherine R.
errShare
errSave
Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis
err2024-06-04
err9
errOAAI
errPatel, Siddharth M.; Kang, Yu Mi; Im, KyungAh; Neuen, Brendon L.; Anker, Stefan D.; Bhatt, Deepak L.; Butler, Javed; Cherney, David Z. I.; Claggett, Brian L.; Fletcher, Robert A.; Herrington, William G.; Inzucchi, Silvio E.; Jardine, Meg J.; Mahaffey, Kenneth W.; McGuire, Darren K.; McMurray, John J. V.; Neal, Bruce; Packer, Milton; Perkovic, Vlado; Solomon, Scott D.; Staplin, Natalie; Vaduganathan, Muthiah; Wanner, Christoph; Wheeler, David C.; Zannad, Faiez; Zhao, Yujie; Heerspink, Hiddo J. L.; Sabatine, Marc S.; Wiviott, Stephen D.
errShare
errSave
Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trial
err2024-05-28
err5
PREAI
errTangri, Navdeep; Ferguson, Thomas W.; Bamforth, Ryan J.; Leon, Silvia J.; Arnott, Clare; Mahaffey, Kenneth W.; Kotwal, Sradha; Heerspink, Hiddo J. L.; Perkovic, Vlado; Fletcher, Robert A.; Neuen, Brendon L.
errShare
errSave
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD
err2024-04-16
err0
PREAI
errFletcher, Robert A.; Herrington, William G.; Agarwal, Rajiv; Mayne, Kaitlin J.; Arnott, Clare; Jardine, Meg J.; Mahaffey, Kenneth W.; Perkovic, Vlado; Staplin, Natalie; Wheeler, David C.; Chertow, Glenn M.; Heerspink, Hiddo J. L.; Neuen, Brendon L.
errShare
errSave
Focal Segmental Glomerulosclerosis Patient Baseline Characteristics in the Sparsentan Phase 3 DUPLEX Study
err2024-04-01
err0
errOAAI
errTrachtman, Howard; Radhakrishnan, Jai; Rheault, Michelle N.; Alpers, Charles E.; Barratt, Jonathan; Heerspink, Hiddo J. L.; Noronha, Irene L.; Perkovic, Vlado; Rovin, Brad; Trimarchi, Hernan; Wong, Muh Geot; Mercer, Alex; Inrig, Jula; Rote, William; Murphy, Ed; Bedard, Patricia W.; Roth, Sandra; Bieler, Stewart; Komers, Radko
errShare
errSave
Kidney Function, Albuminuria, and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis
err2024-03-01
err1
errOAAI
errHa, Jeffrey T.; Ben Freedman, S.; Kelly, Dearbhla M.; Neuen, Brendon L.; Perkovic, Vlado; Jun, Min; Badve, Sunil, V
errShare
errSave
Barriers to Care: New Medications and CKD
err2024-03-01
err2
errOAAI
errKim, Dana; Perkovic, Vlado; Kotwal, Sradha
errShare
errSave
Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial
err2024-02-06
err2
errOAAI
errSharma, Abhinav; Razaghizad, Amir; Joury, Abdulaziz; Levin, Adeera; Bajaj, Harpreet S.; Mancini, G. B. John; Wong, Norman C.; Slee, April; Ang, Fernando G.; Rapattoni, Wally; Neuen, Brendon L.; Arnott, Clare; Perkovic, Vlado; Mahaffey, Kenneth W.
errShare
errSave
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria
err2024-02-06
err52
errOAAI
errNeuen, Brendon L.; Heerspink, Hiddo J. L.; Vart, Priya; Claggett, Brian L.; Fletcher, Robert A.; Arnott, Clare; de Oliveira Costa, Julianna; Falster, Michael O.; Pearson, Sallie-Anne; Mahaffey, Kenneth W.; Neal, Bruce; Agarwal, Rajiv; Bakris, George; Perkovic, Vlado; Solomon, Scott D.; Vaduganathan, Muthiah
errShare
errSave